- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/26 - Glucagons
Patent holdings for IPC class A61K 38/26
Total number of patents in this class: 2497
10-year publication summary
|
167
|
238
|
196
|
248
|
251
|
237
|
244
|
195
|
270
|
124
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novo Nordisk A/S | 2287 |
180 |
| Hanmi Pharm. Co., Ltd. | 570 |
114 |
| Zealand Pharma A/S | 247 |
92 |
| Eli Lilly and Company | 3809 |
89 |
| Sanofi-Aventis Deutschland GmbH | 2638 |
58 |
| MannKind Corporation | 525 |
56 |
| Sanofi | 4008 |
56 |
| Rani Therapeutics, LLC | 197 |
50 |
| Xeris Pharmaceuticals, Inc. | 106 |
40 |
| Intarcia Therapeutics, Inc. | 99 |
31 |
| Adocia | 141 |
29 |
| Shire-nps Pharmaceuticals, Inc. | 38 |
28 |
| Indiana University Research and Technology Corporation | 796 |
27 |
| Boehringer Ingelheim International GmbH | 4701 |
23 |
| Amgen Inc. | 4037 |
20 |
| The Trustees of the University of Pennsylvania | 4304 |
19 |
| MedImmune Limited | 610 |
19 |
| Janssen Pharmaceutica N.V. | 3432 |
18 |
| Nano Precision Medical, Inc. | 35 |
18 |
| Merck Sharp & Dohme LLC | 3739 |
18 |
| Other owners | 1512 |